MetLife Inc. [NYSE: MET] stock went on an upward path that rose over 1.45% on Friday, amounting to a one-week price decrease of less than -7.55%. The company report on October 29, 2020 that MetLife Completes Longevity Reinsurance Transaction with Rothesay.
Metropolitan Tower Life Insurance Company, a subsidiary of MetLife, Inc. (“MetLife”), announced today it has completed a United Kingdom longevity reinsurance transaction with Rothesay Life plc (“Rothesay”).
“Reinsurance solutions play an important role in direct insurers’ ability to secure the retirement benefits of U.K. pensioners,” said Graham Cox, executive vice president and head of Retirement & Income Solutions at MetLife. “This transaction gives MetLife the opportunity to use our mortality expertise and supports Rothesay in its pension de-risking activity.”.
Over the last 12 months, MET stock dropped by -19.11%. The one-year MetLife Inc. stock forecast points to a potential upside of 17.23. The average equity rating for MET stock is currently 2.20, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $33.86 billion, with 908.80 million shares outstanding and 769.04 million shares in the current float. Compared to the average trading volume of 5.45M shares, MET stock reached a trading volume of 6464146 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on MetLife Inc. [MET]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for MET shares is $45.73 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on MET stock is a recommendation set at 2.20. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
BofA/Merrill have made an estimate for MetLife Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on June 01, 2020. While these analysts kept the previous recommendation, Citigroup dropped their target price from $46 to $32. The new note on the price target was released on March 16, 2020, representing the official price target for MetLife Inc. stock. Previously, the target price had yet another raise from $55 to $60, while Morgan Stanley kept a Overweight rating on MET stock.
The Average True Range (ATR) for MetLife Inc. is set at 1.20, with the Price to Sales ratio for MET stock in the period of the last 12 months amounting to 0.50. The Price to Book ratio for the last quarter was 0.45, with the Price to Cash per share for the same quarter was set at 27.15. Price to Free Cash Flow for MET in the course of the last twelve months was 3.26.
MET Stock Performance Analysis:
MetLife Inc. [MET] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -7.55. With this latest performance, MET shares gained by 1.58% in over the last four-week period, additionally plugging by 10.74% over the last 6 months – not to mention a drop of -19.11% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for MET stock in for the last two-week period is set at 45.92, with the RSI for the last a single of trading hit 44.13, and the three-weeks RSI is set at 47.64 for MetLife Inc. [MET]. The present Moving Average for the last 50 days of trading for this stock 38.37, while it was recorded at 37.78 for the last single week of trading, and 38.28 for the last 200 days.
Insight into MetLife Inc. Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and MetLife Inc. [MET] shares currently have an operating margin of +1.39. MetLife Inc.’s Net Margin is presently recorded at +8.47.
Return on Total Capital for MET is now 1.27, given the latest momentum, and Return on Invested Capital for the company is 7.79. Return on Equity for this stock inclined to 9.92, with Return on Assets sitting at 0.83. When it comes to the capital structure of this company, MetLife Inc. [MET] has a Total Debt to Total Equity ratio set at 25.48. Additionally, MET Total Debt to Total Capital is recorded at 20.30, with Total Debt to Total Assets ending up at 2.28. Long-Term Debt to Equity for the company is recorded at 25.12, with the Long-Term Debt to Total Capital now at 20.02.
Reflecting on the efficiency of the workforce at the company, MetLife Inc. [MET] managed to generate an average of $120,388 per employee.
MET Stock EPS
With the latest financial reports released by the company, MetLife Inc. posted 1.27/share EPS, while the average EPS was predicted by analysts to be reported at 1.39/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -8.60%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for MET. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for MetLife Inc. go to 3.31%.
MetLife Inc. [MET] Insider Position Details
There are presently around $26,307 million, or 78.00% of MET stock, in the hands of institutional investors. The top three institutional holders of MET stocks are: BLACKROCK INC. with ownership of 69,956,785, which is approximately 6.569% of the company’s market cap and around 0.10% of the total institutional ownership; DODGE & COX, holding 66,337,971 shares of the stock with an approximate value of $2.51 billion in MET stocks shares; and VANGUARD GROUP INC, currently with $2.35 billion in MET stock with ownership of nearly -2.351% of the company’s market capitalization.
Positions in MetLife Inc. stocks held by institutional investors increased at the end of August and at the time of the August reporting period, where 390 institutional holders increased their position in MetLife Inc. [NYSE:MET] by around 53,288,259 shares. Additionally, 506 investors decreased positions by around 48,865,939 shares, while 149 investors held positions by with 592,885,393 shares. The mentioned changes placed institutional holdings at 695,039,591 shares, according to the latest SEC report filing. MET stock had 82 new institutional investments in for a total of 2,531,246 shares, while 85 institutional investors sold positions of 3,247,938 shares during the same period.